The clinical effect of transvaginal uterine incision in scarpregnancy resection

Objective:To investigate the clinical effects of transvaginal uterine scarpregnancy resection.Methods:Twenty-five patients with scarpregnancy after cesarean section were randomly divided into the control group(17 cases) and observation group(8 cases).The control group were treated with uterine artery methotrexate embolization combined with uterine curettage guilded by B-ultrasonography within 24 hours,and the observation group were treated with transvaginal uterine scarpregnancy resection.The clinical effects between two groups were compared.Results:Twenty-five patients were successfully operated and discharged.The average operation time,hospital expense and postoperative normal menstrual time in observation group were lower than those in control group(P<0.01).The intraoperative blood loss in observation group were higher than that in control group(P<0.01).The differences of the average hospital stay and postoperative blood β-hCG recovery time between two groups were not statistically significant(P>0.05).The results of B ultrasound after 2 weeks of operation showed that the incidence rate of scar mass in observation group(0.00%) was lower than that in control group(52.94%)(P<0.05).There was no statistical significance in the abnormal rate of menstruation between two groups(P>0.05).Conclusions:The transvaginal uterine scarpregnancy resection can one-time remove lesions and scar diverticulum,and is minimally invasive,easy to operate and less postoperative complications,which is worthy of clinical promotion.